Home › Companies › CABALETTA BIO INC. › 2023-2024
At CABALETTA BIO INC.'s shareholder meeting held June 3, 2024, in the 2023-2024 proxy season, 59 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 530 separate fund positions. On the most widely held item on that ballot — To elect two class II directors to our board of directors, to serve until the 2027 annual… — FOR was 69% of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CABALETTA BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CABALETTA BIO INC.’s Form 8-K, filed June 4, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 3, 2024: 3 items on CABALETTA BIO INC.’s Form 8-K, filed June 4, 2024: 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CABALETTA BIO INC. in the interactive database Compare manager voting policies
These tallies are CABALETTA BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Catherine Bollard, MBChB, M.D. | 26,225,488 | -- | -- | 12,001,379 | 3,172,388 | 69% | Not verified | — |
| Elect Director: Richard Henriques, MBA | 37,806,806 | -- | -- | 433,474 | 3,158,975 | 99% | Not verified | — |
| Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, recommended for ratification in Proposal 2 at the Annual M | 41,355,429 | 38,098 | 5,728 | -- | 0 | 99.9% | Not verified | — |
Source: CABALETTA BIO INC., Form 8-K, filed with the SEC on June 4, 2024 — read the filing on EDGAR.
Each item below shows how the 59 asset managers that disclosed a CABALETTA BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
69% Majority: yes · of votes cast
Description as filed by funds: To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Catherine Bollard, MBChB, M.D.
CABALETTA BIO INC.’s own tally for this item (“Elect Director: Catherine Bollard, MBChB, M.D.”): 26,225,488 for, 12,001,379 withheld, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 9,493,626 for, 7,105,554 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 2,510,045 | 0 | 0 | 37,111 | For |
| ALGER FUNDS | 0 | 0 | 0 | 2,449,528 | Withhold |
| Vanguard | 2,191,010 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,012,316 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,810,786 | 0 | 0 | 42,890 | For |
| BlackRock | 0 | 0 | 0 | 1,729,471 | Withhold |
| Invesco | 0 | 0 | 0 | 875,110 | Withhold |
| Fidelity | 475,394 | 0 | 0 | 15,139 | For |
| Victory Capital | 0 | 0 | 0 | 310,292 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 253,608 | Withhold |
| Artisan | 0 | 0 | 0 | 176,171 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 132,458 | Withhold |
| TIAA | 0 | 0 | 0 | 129,618 | Withhold |
| Hartford | 123,770 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 0 | 0 | 0 | 123,044 | Withhold |
| Northwestern Mutual | 112,366 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 0 | 0 | 0 | 104,699 | Withhold |
| Equitable | 6,400 | 0 | 0 | 90,407 | Mixed |
| Charles Schwab | 93,525 | 0 | 0 | 0 | For |
| Neuberger Berman | 0 | 0 | 0 | 81,424 | Withhold |
| Advantage Advisers Xanthus Fund, L.L.C. | 0 | 0 | 0 | 71,682 | Withhold |
| MassMutual | 0 | 0 | 0 | 71,066 | Withhold |
| MUTUAL FUND SERIES TRUST | 70,000 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 63,578 | Withhold |
| Lincoln Financial | 28,800 | 0 | 0 | 16,123 | Mixed |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Richard Henriques, MBA
CABALETTA BIO INC.’s own tally for this item (“Elect Director: Richard Henriques, MBA”): 37,806,806 for, 433,474 withheld, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 16,575,273 for, 23,907 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 2,544,293 | 0 | 0 | 2,863 | For |
| ALGER FUNDS | 2,449,528 | 0 | 0 | 0 | For |
| Vanguard | 2,191,010 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,012,316 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,853,676 | 0 | 0 | 0 | For |
| BlackRock | 1,729,471 | 0 | 0 | 0 | For |
| Invesco | 875,110 | 0 | 0 | 0 | For |
| Fidelity | 490,533 | 0 | 0 | 0 | For |
| Victory Capital | 310,292 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 253,608 | 0 | 0 | 0 | For |
| Artisan | 176,171 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 132,458 | 0 | 0 | 0 | For |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Hartford | 123,770 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 123,044 | 0 | 0 | 0 | For |
| Northwestern Mutual | 112,366 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 104,699 | 0 | 0 | 0 | For |
| Equitable | 96,807 | 0 | 0 | 0 | For |
| Charles Schwab | 93,525 | 0 | 0 | 0 | For |
| Neuberger Berman | 81,424 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 71,682 | 0 | 0 | 0 | For |
| MassMutual | 71,066 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 70,000 | 0 | 0 | 0 | For |
| ProShares | 63,578 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,923 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
CABALETTA BIO INC.’s own tally for this item (“The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, recommended for ratification in Propos”): 41,355,429 for, 38,098 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 16,599,180 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 2,547,156 | 0 | 0 | 0 | For |
| ALGER FUNDS | 2,449,528 | 0 | 0 | 0 | For |
| Vanguard | 2,191,010 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,012,316 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,853,676 | 0 | 0 | 0 | For |
| BlackRock | 1,729,471 | 0 | 0 | 0 | For |
| Invesco | 875,110 | 0 | 0 | 0 | For |
| Fidelity | 490,533 | 0 | 0 | 0 | For |
| Victory Capital | 310,292 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 253,608 | 0 | 0 | 0 | For |
| Artisan | 176,171 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 132,458 | 0 | 0 | 0 | For |
| TIAA | 129,618 | 0 | 0 | 0 | For |
| Hartford | 123,770 | 0 | 0 | 0 | For |
| ALGER PORTFOLIOS | 123,044 | 0 | 0 | 0 | For |
| Northwestern Mutual | 112,366 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 104,699 | 0 | 0 | 0 | For |
| Equitable | 96,807 | 0 | 0 | 0 | For |
| Charles Schwab | 93,525 | 0 | 0 | 0 | For |
| Neuberger Berman | 81,424 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 71,682 | 0 | 0 | 0 | For |
| MassMutual | 71,066 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 70,000 | 0 | 0 | 0 | For |
| ProShares | 63,578 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,923 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 48,276,522 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 5.28% |
| 2 | ALGER FUNDS | 5.07% |
| 3 | Vanguard | 4.54% |
| 4 | T. Rowe Price | 4.17% |
| 5 | Prudential/PGIM | 3.84% |
| 6 | BlackRock | 3.58% |
| 7 | Invesco | 1.81% |
| 8 | Fidelity | 1.02% |
| 9 | Victory Capital | 0.64% |
| 10 | Direxion Shares ETF Trust | 0.53% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Citadel Advisors LLC | 9.71% | 13G |
| Vanguard Group | 8.68% | 13F |
| State Street | 7.75% | 13F |
| BlackRock | 3.36% | 13F |
| Venrock Healthcare Capital Partners III, L.P. | 3.29% | 13G |
| Morgan Stanley | 3.05% | 13F |
| Wellington Management | 2.09% | 13F |
| Geode Capital | 1.60% | 13F |
| Invesco | 1.54% | 13F |
| T. Rowe Price | 1.27% | 13F |
Percentages above are of 48,276,522 shares outstanding, as reported by CABALETTA BIO INC. on its Form 10-Q dated May 10, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CABALETTA BIO INC.’s 10-Q dated May 10, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
CABALETTA BIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “CABALETTA BIO (CABA) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cabaletta-bio-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.